Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-02-28Clinical Trial Update: A Study to Evaluate 3 Dose Levels of Luvadaxistat of Adults With Negative Symptoms of Schizophrenia [Phase 2]
Phase 2 trial evaluating three dose levels of luvadaxistat in adults with negative symptoms of schizophrenia has completed with results post…
-
CLINICAL_TRIALS trial_result · 2024-02-28Clinical Trial Update: A Study to Evaluate Multiple Oral Doses of Luvadaxistat in Adults With Schizophrenia [Phase 2]
Phase 2 study assessing multiple oral doses of luvadaxistat in adults with schizophrenia has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2024-02-26Clinical Trial Update: Cognitive Effects of Adjuvant Vortioxetine in Early Schizophrenia [Phase 2, Phase 3]
A Phase 2/3 clinical trial update examining cognitive effects of adjuvant vortioxetine in early schizophrenia is ongoing, with unspecified s…
-
CLINICAL_TRIALS trial_result · 2024-02-08Clinical Trial Update: Varenicline Treatment in Alcohol and Nicotine Dependent Patients With Schizophrenia [Phase 4]
Phase 4 clinical trial evaluating varenicline for individuals with schizophrenia or schizoaffective disorder who are also dependent on alcoh…
-
CLINICAL_TRIALS trial_result · 2024-02-08Clinical Trial Update: Adjunctive Vortioxetine in Schizophrenia [Phase 4]
Phase 4 clinical trial update evaluating adjunctive vortioxetine for schizophrenia with focus on negative symptoms.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-02-05Clinical Trial Update: Pharmacological Modulation of Hippocampal Activity in Psychosis 2 [Phase 2]
Phase 2 trial assessing pharmacological modulation of hippocampal activity for schizophrenia/psychosis completed with posted results.
-
CLINICAL_TRIALS trial_result · 2024-02-02Clinical Trial Update: Project Bridge: Peer Health Navigator Intervention [NA]
A completed clinical trial (Project Bridge) evaluating a Peer Health Navigator intervention for schizophrenia and depression; results posted…
-
CLINICAL_TRIALS trial_result · 2023-12-22Clinical Trial Update: A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-692 as an Adjunctive Treatment in Adults With Schizophrenia [Phase 2]
Phase 2 trial completed evaluating CTP-692 as an adjunctive treatment for adults with schizophrenia; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-12-20Clinical Trial Update: Trial to Evaluate the Short-term Safety & Efficacy of Brexpiprazole Monotherapy in the Treatment of Adolescents With Schizophrenia [Phase 3]
Phase 3 trial evaluating short-term safety and efficacy of brexpiprazole monotherapy in adolescents with schizophrenia has completed with re…
-
CLINICAL_TRIALS trial_result · 2023-12-12Clinical Trial Update: A Study to Assess Efficacy and Safety of KarXT in Acutely Psychotic Hospitalized Adult Patients With Schizophrenia (EMERGENT-2) [Phase 3]
Phase 3 study EMERGENT-2 evaluating KarXT for acutely psychotic hospitalized adults with schizophrenia has completed; results were posted in…
-
CLINICAL_TRIALS trial_result · 2023-11-28Clinical Trial Update: Bazedoxifene -Treatment for Women With Schizophrenia [Phase 4]
Phase 4 clinical trial investigating bazedoxifene as a treatment for schizophrenia-related conditions.
-
CLINICAL_TRIALS trial_result · 2023-11-28Clinical Trial Update: Aripiprazole Lauroxil for Preventing Psychotic Relapse After an Initial Schizophrenia Episode [Phase 4]
Phase 4 trial updating on aripiprazole lauroxil for preventing psychotic relapse after an initial schizophrenia episode; terminated with res…
-
CLINICAL_TRIALS trial_result · 2023-11-28Clinical Trial Update: Selective Estrogen Receptor Modulators (SERMs) - A Potential Treatment for Psychotic Symptoms of Schizophrenia in Men? [Phase 4]
Phase 4 trial investigating selective estrogen receptor modulators (SERMs) as a potential treatment for psychotic symptoms in men with schiz…
-
CLINICAL_TRIALS trial_result · 2023-11-18Clinical Trial Update: This Study Tests Whether BI 425809 Together With Brain Training Using a Computer Improves Mental Functioning in Patients With Schizophrenia [Phase 2]
A Phase 2 study evaluating BI 425809 with computer-based brain training to improve mental function in schizophrenia has completed and posted…
-
CLINICAL_TRIALS trial_result · 2023-11-18Clinical Trial Update: A Trial of Multiple-doses of Aripiprazole in Adults With Schizophrenia or Bipolar 1 Disorder [Phase 1, Phase 2]
A multi-dose aripiprazole trial in adults with schizophrenia or Bipolar I Disorder has completed phases 1 and 2, with results posted in 2023…
-
CLINICAL_TRIALS trial_result · 2023-11-09Clinical Trial Update: Exploring the Effect of Rumination-Focused Cognitive Behaviour Therapy in Patients With Schizophrenia [NA]
A completed randomized controlled trial assessing rumination-focused cognitive-behavior therapy in patients with schizophrenia; results post…
-
CLINICAL_TRIALS trial_result · 2023-11-03Clinical Trial Update: Using Digital Media Advertising to Reduce the Duration of Untreated Psychosis [NA]
A completed clinical trial evaluated the use of digital media advertising to reduce the duration of untreated psychosis.
-
CLINICAL_TRIALS trial_result · 2023-11-01Clinical Trial Update: Efficacy and Safety Study of Aripiprazole to Treat Schizophrenia [Phase 2]
Phase 2 trial update evaluating the efficacy and safety of aripiprazole for schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2023-10-23Clinical Trial Update: Evaluating Sublingual Dexmedetomidine For Moderate To Severe Agitation In Inpatients With Schizophrenia Or Bipolar Disorder [Phase 4]
Phase 4 clinical trial evaluating sublingual dexmedetomidine for moderate to severe agitation in inpatients with schizophrenia or bipolar di…
-
CLINICAL_TRIALS trial_result · 2023-10-10Clinical Trial Update: A Trial of the Efficacy and the Safety of RO6889450 (Ralmitaront) vs Placebo in Patients With an Acute Exacerbation of Schizophrenia or Schizoaffective Disorder [Phase 2]
Phase 2 trial evaluating the efficacy and safety of RO6889450 (ralmitaront) versus placebo in acute exacerbations of schizophrenia or schizo…
-
CLINICAL_TRIALS trial_result · 2023-09-29Clinical Trial Update: Multidisciplinary Design to Optimize Schizophrenia Treatment Based on Multi-omics Data and Systems Biology Analysis [Phase 4]
Phase 4 clinical trial update exploring multidisciplinary design to optimize schizophrenia treatment using multi-omics data and systems biol…
-
CLINICAL_TRIALS trial_result · 2023-09-07Clinical Trial Update: The Impact of the COVID-19 (SARS-CoV-2 Disease) on Psychopathology
Clinical trial completed examining the impact of COVID-19 on psychopathology, with results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-09-07Clinical Trial Update: Switching From Twice-Daily to Once-Daily Clozapine Dosing in Schizophrenia [Phase 4]
Phase 4 trial update evaluating switching from twice-daily to once-daily clozapine dosing in schizophrenia and schizoaffective disorder.
-
CLINICAL_TRIALS trial_result · 2023-09-01Clinical Trial Update: Song-making In a Group (SING) R61 [NA]
Completed results have been posted for the SING (Song-making In a Group) R61 study at Yale, evaluating a group-based intervention for schizo…
-
CLINICAL_TRIALS trial_result · 2023-08-22Clinical Trial Update: Topiramate vs Metformin on Cardio-Metabolic Profile in Schizophrenia on Atypical Antipsychotics [Phase 4]
Phase 4 clinical trial comparing topiramate and metformin on cardio-metabolic outcomes in schizophrenia patients treated with atypical antip…